Skip Navigation

Human Molecular Genetics 2007 16(R1):R106-R113; doi:10.1093/hmg/ddm056
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Blenkiron, C.
Right arrow Articles by Miska, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blenkiron, C.
Right arrow Articles by Miska, E. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

miRNAs in cancer: approaches, aetiology, diagnostics and therapy

Cherie Blenkiron and Eric A. Miska*

The Wellcome Trust/Cancer Research, UK Gurdon Institute and Department of Biochemistry, University of Cambridge, The Henry Wellcome Building of Cancer and Developmental Biology, Tennis Court Road, Cambridge CB2 1QN, UK

* To whom correspondence should be addressed at: Tel: +44 1223767220; Fax: +44 1223767225; Email: eam29{at}cam.ac.uk

Received February 22, 2007; Accepted March 2, 2007

MicroRNAs (miRNAs) are causing tremendous excitement in cancer research. MiRNAs are a large class of short non-coding RNAs that are found in many plants, animals and DNA viruses and often act to inhibit gene expression post-transcriptionally. Approximately 500 miRNA genes have been identified in the human genome. Their function is largely unknown, but data from worms, flies, fish and mice suggest that they have important roles in animal growth, development, homeostasis and disease. MiRNA expression profiles demonstrate that many miRNAs are deregulated in human cancers. MiRNAs have been shown to regulate oncogenes, tumour suppressors and a number of cancer-related genes controlling cell cycle, apoptosis, cell migration and angiogenesis. MiRNAs encoded by the mir-17-92 cluster have oncogenic potential and others may act as tumour suppressors. Some miRNAs and their target sites were found to be mutated in cancer. MiRNAs may have great diagnostic potential for human cancer and even miRNA-based cancer therapies may be on the horizon.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
S M Metias, E Lianidou, and G M Yousef
MicroRNAs in clinical oncology: at the crossroads between promises and problems
J. Clin. Pathol., September 1, 2009; 62(9): 771 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., April 15, 2009; 15(8): 2850 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
Q. Jiang, Y. Wang, Y. Hao, L. Juan, M. Teng, X. Zhang, M. Li, G. Wang, and Y. Liu
miR2Disease: a manually curated database for microRNA deregulation in human disease
Nucleic Acids Res., January 1, 2009; 37(suppl_1): D98 - D104.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. Ylosmaki, T. Hakkarainen, A. Hemminki, T. Visakorpi, R. Andino, and K. Saksela
Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA
J. Virol., November 15, 2008; 82(22): 11009 - 11015.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
O. Kovalchuk, J. Filkowski, J. Meservy, Y. Ilnytskyy, V. P. Tryndyak, V. F. Chekhun, and I. P. Pogribny
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Mol. Cancer Ther., July 1, 2008; 7(7): 2152 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
C. Zhang
MicroRNomics: a newly emerging approach for disease biology
Physiol Genomics, April 1, 2008; 33(2): 139 - 147.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.